```html

Viral Upper Respiratory Infection (URI)

Overview

A viral upper respiratory infection (URI) refers to a group of contagious illnesses that affect the nose, throat, sinuses, and sometimes the larynx. Common names include the “common cold,” viral pharyngitis, and “acute viral rhinosinusitis.” Unlike bacterial infections, URIs are almost always caused by viruses, so antibiotics are not effective.

Who it affects: Almost everyone contracts a viral URI at some point. Children experience the highest rates—averaging 6–8 colds per year—while adults typically have 2–3 infections annually.<sup>1</sup>

Prevalence: In the United States, an estimated 20–30 million people seek medical care for a URI each year, costing the healthcare system over $40 billion in direct and indirect expenses (lost workdays, over‑the‑counter medications, etc.).<sup>2</sup>

Symptoms

Symptoms usually appear 1–3 days after exposure and last 5–10 days, though some may linger for up to two weeks.

• Nasopharyngeal congestion – a feeling of “stuffiness” caused by swollen nasal mucosa.
• Rhinorrhea – clear, watery discharge that may become thicker and yellowish as the infection progresses.
• Sneezing – reflex response to irritation of the nasal lining.
• Sore throat (pharyngitis) – scratchy or burning sensation, often worse with swallowing.
• Cough – typically dry early on, becoming productive (phlegm) later.
• Hoarseness – irritation of the larynx can cause a raspy voice.
• Headache – sinus pressure or mild tension headache.
• Low‑grade fever – < 38.5 °C (101.3 °F); more common in children.
• Malaise & fatigue – feeling unusually tired or “run down.”
• Reduced appetite – especially in children.

Red‑flag symptoms that suggest a bacterial superinfection or another condition (see When to Seek Emergency Care) include high fever (> 39 °C/102 °F), facial pain that worsens with bending, thick green or blood‑tinged sputum, or difficulty breathing.

Causes and Risk Factors

Common viral culprits

• Rhinoviruses – responsible for 30–50 % of colds.
• Coronaviruses (non‑SARS/MERS strains) – 10–15 % of cases.
• Respiratory syncytial virus (RSV) – especially in infants and the elderly.
• Influenza viruses – can present initially as a URI before progressing to pneumonia.
• Parainfluenza, adenovirus, enterovirus – less common but still prevalent.

Risk factors that increase susceptibility

• Age: Children under 5 and adults over 65 have weaker innate immunity.
• Close‑contact environments: Schools, daycare centers, nursing homes, and crowded workplaces.
• Seasonality: Higher incidence during fall and winter in temperate climates due to indoor crowding and lower humidity.
• Smoking or exposure to second‑hand smoke: Damages respiratory epithelium, making viral attachment easier.
• Underlying chronic illnesses: Asthma, COPD, diabetes, or immunocompromising conditions.
• Stress, poor sleep, and malnutrition: All weaken the immune response.

Diagnosis

In most cases the diagnosis is clinical—based on history and physical examination.

Typical clinical assessment

1. Review of symptom timeline, exposure history, and vaccination status.
2. Physical exam: inspection of nasal mucosa, throat, and auscultation of lungs.
3. Assessment of severity (e.g., fever, dehydration, breathing difficulty).

When additional tests are needed

If a bacterial superinfection, influenza, COVID‑19, or another condition is suspected, clinicians may order:

• Rapid antigen test for influenza or COVID‑19 – results in minutes.
• Complete blood count (CBC) – may show mild leukocytosis in bacterial cases.
• Throat culture or rapid streptococcal antigen test – to rule out streptococcal pharyngitis.
• Chest X‑ray – if lower‑respiratory involvement is suspected.

Treatment Options

Because viruses are not killed by antibiotics, management focuses on relieving symptoms, supporting the immune system, and preventing complications.

Medications

• Analgesics/Antipyretics: Acetaminophen or ibuprofen for fever, headache, and sore throat.
• Decongestants: Oral pseudoephedrine or topical oxymetazoline for short‑term nasal relief (max 3 days for topical agents).
• Antihistamines: First‑generation (diphenhydramine) or second‑generation (loratadine) for runny nose and sneezing.
• Cough suppressants: Dextromethorphan for dry cough; expectorants (guaifenesin) for productive cough.
• Zinc lozenges: May modestly reduce duration if started within 24 h of symptom onset (25 mg elemental zinc, 5 days).<sup>3</sup>
• Prescription antivirals: Reserved for influenza (oseltamivir) or RSV in high‑risk patients.

Lifestyle and supportive care

• Increase fluid intake – water, broths, herbal teas.
• Rest – sleep supports immune function.
• Humidified air – use a cool‑mist humidifier or take steamy showers to ease congestion.
• Saline nasal irrigation – reduces mucus and improves comfort (e.g., neti pot, saline spray).
• Good hand hygiene – frequent washing with soap for at least 20 seconds.

When antibiotics are appropriate

Only if a bacterial complication is confirmed or strongly suspected (e.g., bacterial sinusitis lasting > 10 days, streptococcal pharyngitis, or secondary bacterial pneumonia). Overuse contributes to antimicrobial resistance.

Living with Viral Upper Respiratory Infection

Daily management tips

• Stay home: Limit contact with others for at least 24 h after fever resolves to curb spread.
• Monitor temperature: Keep a log; seek care if fever persists > 3 days.
• Nutrition: Eat light, nutrient‑dense meals (soups, fruits, vegetables) to maintain energy.
• Voice care: Rest the voice if hoarseness persists; use warm tea with honey.
• Medication schedule: Follow dosing intervals; avoid combining multiple decongestants.
• Sleep hygiene: Keep bedroom cool, dark, and quiet; aim for 7–9 hours.
• Hydration tricks: Add electrolyte solutions or oral rehydration salts if fever leads to sweating.
• Track symptoms: Use a simple checklist (fever, cough, breathing difficulty) to note changes.

Returning to work or school

Most adults can resume normal activities once they feel well, fever‑free for 24 h, and are no longer contagious (usually 5–7 days after onset). Children may need a longer clearance period, especially if they have a lingering cough that interferes with sleep.

Prevention

• Hand hygiene: Wash hands regularly; alcohol‑based sanitizers are a good backup.
• Respiratory etiquette: Cover mouth/nose with a tissue or elbow when coughing/sneezing.
• Avoid touching face: Viruses enter through eyes, nose, and mouth.
• Vaccination: Annual influenza vaccine reduces flu‑related URIs by 40‑60 %.<sup>4</sup> No vaccine exists for most common cold viruses, but COVID‑19 vaccination prevents a major viral respiratory illness.
• Environmental measures: Increase indoor humidity (30‑50 %) in winter, improve ventilation, and clean high‑touch surfaces.
• Healthy lifestyle: Balanced diet rich in vitamins A, C, D, regular exercise, adequate sleep, and stress management strengthen immunity.

Complications

Most viral URIs resolve without sequelae, but complications can arise, especially in vulnerable populations.

• Acute bacterial sinusitis: Occurs in 5‑10 % of colds; presents with facial pain, purulent nasal discharge, and symptoms lasting > 10 days.
• Otitis media: Middle‑ear infection common in children; may cause ear pain, fever, and temporary hearing loss.
• Exacerbation of asthma or COPD: Viral inflammation can trigger bronchospasm, wheezing, and increased medication use.
• Pneumonia: Secondary bacterial pneumonia follows a viral URI in about 2 % of adults; characterized by high fever, productive cough, and shortness of breath.
• Upper airway obstruction: Rare but possible in infants with severe swelling (e.g., croup‑like presentation).
• Myositis or myocarditis: Very rare viral complications causing muscle pain or cardiac inflammation.

When to Seek Emergency Care

References

1. Heikkinen T, Järvinen A. The common cold. The Lancet. 2003;361(9351):51‑59.
2. Centers for Disease Control and Prevention. Economic Burden of Non‑Influenza Respiratory Viruses. 2020.
3. Science Daily. Zinc lozenges may shorten the duration of the common cold. 2021.
4. World Health Organization. Influenza (Seasonal) Fact Sheet. Updated 2023.
5. Mayo Clinic. Upper respiratory infection (cold). Accessed May 2026.

```